IGF-binding protein 2 is a candidate target of therapeutic potential in cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IGF-binding protein 2 is a candidate target of therapeutic potential in cancer
Authors
Keywords
IGFBP2, Metastasis, Target therapy, Biomarker, Tyrosine kinase inhibitor
Journal
TUMOR BIOLOGY
Volume 37, Issue 2, Pages 1451-1459
Publisher
Springer Nature
Online
2015-12-11
DOI
10.1007/s13277-015-4561-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of PKR impairs angiogenesis through a VEGF pathway
- (2015) Zhaowei Zhu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
- (2015) Kyle G. Halvorson et al. PLoS One
- Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer
- (2014) Sarah J. R. Dean et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Integrins
- (2014) Cui-Cui Sun et al. ANTI-CANCER DRUGS
- A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
- (2014) B A Wilky et al. BRITISH JOURNAL OF CANCER
- A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
- (2014) I Brana et al. BRITISH JOURNAL OF CANCER
- Exogenous IGFBP-2 promotes proliferation, invasion and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer
- (2014) Yin Cao et al. INTERNATIONAL JOURNAL OF CANCER
- Strategies To Inhibit Tumor Associated Integrin Receptors: Rationale for Dual and Multi-Antagonists
- (2014) Helen M. Sheldrake et al. JOURNAL OF MEDICINAL CHEMISTRY
- Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex
- (2014) Jacob Lund et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- PTEN regulation of the proliferation and differentiation of auditory progenitors through the PTEN/PI3K/Akt-signaling pathway in mice
- (2014) Chen Sun et al. NEUROREPORT
- Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis
- (2014) Jing-Xun Wu et al. PLoS One
- Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
- (2014) Edyta Wieczorek et al. TUMOR BIOLOGY
- Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- (2013) M. L. Neuhouser et al. Cancer Prevention Research
- INK4a/ARF limits the expansion of cells suffering from replication stress
- (2013) Angela Monasor et al. CELL CYCLE
- Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor
- (2013) I. McCaffery et al. CLINICAL CANCER RESEARCH
- Circulating IGF system and treatment outcome in epithelial ovarian cancer
- (2013) Yu-Fang Huang et al. ENDOCRINE-RELATED CANCER
- Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
- (2013) K M Biernacka et al. ENDOCRINE-RELATED CANCER
- Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor
- (2013) Emily J. Foulstone et al. ENDOCRINOLOGY
- Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer
- (2013) Miloš Šunderić et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells
- (2013) Xiaoli Chen et al. Journal of Hematology & Oncology
- Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues
- (2013) Narges Ahani et al. MEDICAL ONCOLOGY
- Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis
- (2013) Priyanka Sehgal et al. Molecular Cancer
- IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non-Small Cell Lung Cancer Cells
- (2013) H. Lu et al. MOLECULAR CANCER THERAPEUTICS
- Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
- (2013) Z Kang et al. ONCOGENE
- CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis
- (2012) T. Jiang et al. BLOOD
- Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
- (2012) S Rohrmann et al. BRITISH JOURNAL OF CANCER
- MDA-9/Syntenin and IGFBP-2 Promote Angiogenesis in Human Melanoma
- (2012) S. K. Das et al. CANCER RESEARCH
- Insulin-Like Growth Factor (IGF) Binding Protein 2 Functions Coordinately with Receptor Protein Tyrosine Phosphatase and the IGF-I Receptor To Regulate IGF-I-Stimulated Signaling
- (2012) X. Shen et al. MOLECULAR AND CELLULAR BIOLOGY
- Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression
- (2012) A Ben-Shmuel et al. ONCOGENE
- Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF- B network
- (2012) K. M. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High IGFBP2 Expression Correlates with Tumor Severity in Pediatric Rhabdomyosarcoma
- (2011) Lucia Tombolan et al. AMERICAN JOURNAL OF PATHOLOGY
- Insulin-like growth factor binding protein-2: NMR analysis and structural characterization of the N-terminal domain
- (2011) Charles A. Galea et al. BIOCHIMIE
- Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel
- (2011) C C Uzoh et al. BRITISH JOURNAL OF CANCER
- Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer
- (2011) Mari-Anne Rowlands et al. CANCER CAUSES & CONTROL
- The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
- (2011) Giorgio V. Scagliotti et al. CANCER TREATMENT REVIEWS
- IGFBP-2 Enhances VEGF Gene Promoter Activity and Consequent Promotion of Angiogenesis by Neuroblastoma Cells
- (2011) Walid J. Azar et al. ENDOCRINOLOGY
- The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton
- (2011) Masanobu Kawai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia
- (2011) Andrea Kühnl et al. LEUKEMIA RESEARCH
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway
- (2011) A A Wani et al. ONCOGENE
- Role of Insulin-Like Growth Factor Binding Protein 2 in Lung Adenocarcinoma
- (2010) Toshiro Migita et al. AMERICAN JOURNAL OF PATHOLOGY
- High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2
- (2010) Monalisa Swain et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- IGFBP2 promotes glioma tumor stem cell expansion and survival
- (2010) David Hsieh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Patched1 Inhibits Epidermal Progenitor Cell Expansion and Basal Cell Carcinoma Formation by Limiting Igfbp2 Activity
- (2010) R. M. Villani et al. Cancer Prevention Research
- IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription
- (2010) Matei Mireuta et al. GROWTH FACTORS
- Plasma Insulin-Like Growth Factor-Binding Protein-2 Levels as Diagnostic and Prognostic Biomarker of Colorectal Cancer
- (2010) Jyh-Ming Liou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas
- (2009) L. M. Moore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis
- (2009) Stephen B. Wheatcroft et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation
- (2008) C. C. Zhang et al. BLOOD
- IGFBP2 and IGFBP5 Overexpression Correlates With the Lymph Node Metastasis in T1 Breast Carcinomas
- (2008) Huamin Wang et al. Breast Journal
- Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer
- (2008) A. I. So et al. CLINICAL CANCER RESEARCH
- IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis
- (2008) Daniela Diehl et al. INTERNATIONAL JOURNAL OF CANCER
- IGFBP2 Is Overexpressed by Pediatric Malignant Astrocytomas and Induces the Repair Enzyme DNA-PK
- (2008) Oren J. Becher et al. JOURNAL OF CHILD NEUROLOGY
- PAPA-1 Is a Nuclear Binding Partner of IGFBP-2 and Modulates Its Growth-Promoting Actions
- (2008) Kenichi Miyako et al. MOLECULAR ENDOCRINOLOGY
- Insulin-like growth factor-binding proteins and bone metabolism
- (2007) Cheryl A. Conover AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More